We also showed that VCAM1 inhibition (both pharmacological and endothelial cell-specific genetic deletion) attenuated proinflammatory monocyte hepatic infiltration, and thereby alleviated liver fibrosis in diet-induced murine NASH models (6). The gene discussed is VCAM1; the disease is metabolic dysfunction-associated steatohepatitis.